市場調査レポート

商品コード

1403415

関節痛注射の2030年までの市場予測：関節タイプ、注射タイプ、流通チャネル、エンドユーザー、地域別の世界分析

Joint Pain Injections Market Forecasts to 2030 - Global Analysis By Joint Type (Shoulder and Elbow, Facet Joints of the Spine, Knee and Ankle, Hip Joint and Other Joint Types), Injection Type, Distribution Channel, End User and By Geography

出版日: 2024年01月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 610,008円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 771,697円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 933,386円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,102,425円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、世界の関節痛注射市場は2023年に52億米ドルを占め、予測期間中のCAGRは10.6％で成長し、2030年には107億米ドルに達すると予想されています。

関節への直接注射は、腫れや炎症を抑えるために関節痛の治療に用いられます。高齢者では、関節の不快感は一般的に既往症によってもたらされます。関節炎として知られる広範な病気は、主に股関節、膝関節、肘関節、肩関節、脊椎のファセット関節に影響を及ぼします。関節炎は関節に炎症を引き起こし、不快にさせます。

Arthritis Research UKの報告書"The State of Musculoskeletal Health 2018"によると、英国では1,780万人が筋骨格系の症状に苦しんでいると推定されており、これは同国の総人口の約28.9%に相当します。

関節炎の増加

成人障害の原因として世界で最も頻度が高いのは関節炎です。例えば副腎皮質ステロイドやヒアルロン酸の注射は、関節を潤滑にし炎症を抑えることで痛みを大幅に軽減し、こわばりや不快感を和らげることができます。痛みや炎症のある部位に注意深く薬を投与することで、注射は患部の関節を狙い撃ちし、効果を高め、全身的な副作用を最小限に抑えます。このような背景から市場は拡大しています。

副作用とアレルギー

患者が経験した関節痛注射の副作用やアレルギーは、市場拡大の大きな障壁となっています。関節痛の注射を受けた患者の中には、軟骨や神経にダメージを受けた人もおり、こうした医療機器の製造・販売に影響を与えています。さらに、業界拡大の最大の障害は、患者が関節痛の予防注射を使用した結果生じる皮膚の変色や感染症であることが示されています。

関節関連疾患の有病率の増加

市場促進要因の1つは、関節関連疾患の有病率の増加です。変形性関節症や関節リウマチのような疾患の発生率の増加は、関節痛注射を含む効果的な疼痛管理ソリューションに対する大きな需要を生み出しています。高齢化人口の増加、座りっぱなしのライフスタイル、スポーツに関連した怪我がさらに市場の成長に寄与しています。

知識不足

平均的な人々は関節痛の注射について聞いたことがないです。多血小板血漿、コルチコステロイド、ヒアルロン酸注射は、関節の不快感を和らげるために使われます。これらの注射を利用するには、かなりの専門知識と訓練が必要です。医師や他の医療専門家は、頻繁に関節の不快感のための人々を注射します。専門家がこれを行うために必要なツールとトレーニングが提供されます。しかし、関節痛の注射を奨励する政府の施策がないため、市場の成長は限られています。

COVID-19の影響：

COVID-19パンデミックは、実質的にあらゆるビジネスに影響を及ぼす、他に類を見ない世界の公衆衛生上の災害であることが判明しており、その反響は予測期間中、あらゆる産業の成長に影響を及ぼすと予想されます。世界的に、サプライチェーンの経路変更、購買パターン、顧客の需要と行動、政府の主要な取り組みにいくつかの変化が生じています。流行病は、人々のライフスタイル、薬物使用パターン、その他の健康関連の習慣を変化させました。

予測期間中、ヒアルロン酸注射分野が最大になる見込み

ヒアルロン酸注入セグメントは予測期間中最大になると予想されます。アセトアミノフェンや他のオピオイドのような効果のない治療をすでに試した患者は、変形性関節症に伴う膝の不快感に対してヒアルロン酸注射で治療を受けています。ヒアルロン酸注射は、特に、医師が一般的に関節内コルチコステロイド注射を定期的に行うことに消極的であることを考慮すると、非外科的治療の選択肢として支持を集めています。

予測期間中にCAGRが最も高くなると予想されるのは病院薬局セグメントです。

病院薬局セグメントは予測期間中最も高いCAGRが見込まれます。病院薬局では、有能な薬剤師に加え、注射剤投与に関する特別な訓練を受けた医療専門家が頻繁に雇用されているため、正しい手技が保証され、問題が発生する可能性が低くなります。患者は、特定のニーズに合わせたさまざまな種類の注射や併用療法など、より幅広い疼痛管理の選択肢を利用できます。

最大のシェアを占める地域

北米は、筋骨格系障害の有病率が高く、老年人口が増加しているため、予測期間中最大の市場シェアを占めると予測されます。これは、この地域に市場参入企業が集中していること、この地域に業界企業がしっかりと存在していること、ヘルスケアインフラが改善されていること、利用可能なテクノロジーに関する一般市民や業界利害関係者の知識が豊富であることなど、多くの要因によるものです。この地域の市場は、最先端技術の採用率の高さもあって拡大しています。

CAGRが最も高い地域：

予測期間中、アジア太平洋地域が最も高いCAGRを維持すると予測されます。変形性関節症の罹患率の上昇と、地域の競合企業によるビスコサプリメント製品の参入が、各国の各市場の成長を後押ししています。さらに、最先端の関節痛治療に関する知識の普及により、これらの治療法が患者に受け入れられる理想的な状況が生まれています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場プレイヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東とアフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第10章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第11章企業プロファイル

Anika Therapeutics, Inc.
Sanofi aventis LLC
Ferring B.V.
Zimmer Biomet
Bioventus LLC
Allergen Plc.
Pfizer Inc.
Chugai Pharmaceutical Co. Ltd
SEIKAGAKU Corporation
Ferring B.V.
Pacira Biosciences
OrthogenRx
Pfizer
Lifecore Biomedical
Wright Medical Group
AbbVie
Stryker

図表

List of Tables

Table 1 Global Joint Pain Injections Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
Table 3 Global Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
Table 4 Global Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
Table 5 Global Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
Table 6 Global Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
Table 7 Global Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
Table 8 Global Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
Table 9 Global Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
Table 10 Global Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
Table 11 Global Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
Table 12 Global Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
Table 13 Global Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
Table 14 Global Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
Table 15 Global Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 16 Global Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 17 Global Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 18 Global Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 19 Global Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
Table 20 Global Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
Table 21 Global Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
Table 22 Global Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
Table 23 North America Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
Table 24 North America Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
Table 25 North America Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
Table 26 North America Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
Table 27 North America Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
Table 28 North America Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
Table 29 North America Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
Table 30 North America Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
Table 31 North America Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
Table 32 North America Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
Table 33 North America Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
Table 34 North America Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
Table 35 North America Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
Table 36 North America Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
Table 37 North America Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 38 North America Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 39 North America Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 40 North America Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 41 North America Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
Table 42 North America Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
Table 43 North America Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
Table 44 North America Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
Table 45 Europe Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
Table 46 Europe Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
Table 47 Europe Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
Table 48 Europe Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
Table 49 Europe Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
Table 50 Europe Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
Table 51 Europe Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
Table 52 Europe Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
Table 53 Europe Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
Table 54 Europe Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
Table 55 Europe Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
Table 56 Europe Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
Table 57 Europe Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
Table 58 Europe Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
Table 59 Europe Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 60 Europe Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 61 Europe Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 62 Europe Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 63 Europe Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
Table 64 Europe Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
Table 65 Europe Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
Table 66 Europe Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
Table 67 Asia Pacific Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
Table 68 Asia Pacific Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
Table 69 Asia Pacific Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
Table 70 Asia Pacific Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
Table 71 Asia Pacific Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
Table 72 Asia Pacific Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
Table 73 Asia Pacific Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
Table 74 Asia Pacific Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
Table 75 Asia Pacific Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
Table 76 Asia Pacific Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
Table 77 Asia Pacific Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
Table 78 Asia Pacific Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
Table 79 Asia Pacific Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
Table 80 Asia Pacific Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
Table 81 Asia Pacific Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 82 Asia Pacific Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 83 Asia Pacific Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 84 Asia Pacific Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 85 Asia Pacific Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
Table 86 Asia Pacific Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
Table 87 Asia Pacific Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
Table 88 Asia Pacific Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
Table 89 South America Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
Table 90 South America Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
Table 91 South America Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
Table 92 South America Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
Table 93 South America Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
Table 94 South America Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
Table 95 South America Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
Table 96 South America Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
Table 97 South America Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
Table 98 South America Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
Table 99 South America Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
Table 100 South America Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
Table 101 South America Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
Table 102 South America Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
Table 103 South America Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 104 South America Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 105 South America Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 106 South America Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 107 South America Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
Table 108 South America Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
Table 109 South America Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
Table 110 South America Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
Table 111 Middle East & Africa Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
Table 112 Middle East & Africa Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
Table 113 Middle East & Africa Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
Table 114 Middle East & Africa Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
Table 115 Middle East & Africa Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
Table 116 Middle East & Africa Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
Table 117 Middle East & Africa Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
Table 118 Middle East & Africa Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
Table 119 Middle East & Africa Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
Table 120 Middle East & Africa Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
Table 121 Middle East & Africa Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
Table 122 Middle East & Africa Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
Table 123 Middle East & Africa Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
Table 124 Middle East & Africa Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
Table 125 Middle East & Africa Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 126 Middle East & Africa Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 127 Middle East & Africa Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 128 Middle East & Africa Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 129 Middle East & Africa Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
Table 130 Middle East & Africa Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
Table 131 Middle East & Africa Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
Table 132 Middle East & Africa Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)

Product Code: SMRC24640

According to Stratistics MRC, the Global Joint Pain Injections Market is accounted for $5.2 billion in 2023 and is expected to reach $10.7 billion by 2030 growing at a CAGR of 10.6% during the forecast period. Direct injections into the joints are used to treat joint pain in order to reduce swelling and inflammation. In the elderly population, joint discomfort is typically brought on by pre-existing conditions. The widespread ailment known as arthritis mostly affects the hip, knee, elbow, shoulder, and facet joints of the spine. It causes inflammation in the joints and makes them uncomfortable.

According to the Arthritis Research UK report, "The State of Musculoskeletal Health 2018", it is estimated that 17.8 million people suffer with a musculoskeletal condition in the UK which is around 28.9% of the total population of the country.

Market Dynamics:

Driver:

Increased occurrence of arthritis

The most frequent cause of adult disability worldwide is arthritis. Corticosteroids and hyaluronic acid injections, for example, can significantly reduce pain by lubricating the joints and decreasing inflammation, which relieves stiffness and discomfort. By carefully administering medicine to the region of pain or inflammation, injections target the afflicted joint, increasing efficacy and minimizing systemic adverse effects. The market is expanding as a result of these causes.

Restraint:

Side effects and allergies

Joint pain injection side effects and allergies that patients experienced have turned out to be a significant barrier to the market's expansion. Some patients who had joint pain injections had damage to their cartilage and nerves, which has had an impact on the manufacturing and marketing of these medical devices. Furthermore, the largest obstacle to the industry's expansion has been shown to be skin discoloration and infections that result from patients using joint pain inoculations.

Opportunity:

Growing prevalence of joint-related disorders

One driver of the market is the growing prevalence of joint-related disorders. The increasing incidence of conditions such as osteoarthritis and rheumatoid arthritis has created a substantial demand for effective pain management solutions, including joint pain injections. The rising aging population, sedentary lifestyles, and sports-related injuries further contribute to the market growth.

Threat:

Lack of knowledge

The average population has never heard about joint pain injections. Platelet-rich plasma, corticosteroids, and hyaluronic acid injections are used to relieve joint discomfort. To utilize these injections, one must possess a great deal of expertise and training. Physicians and other medical professionals frequently inject people for joint discomfort. The tools and training needed for professionals to do this are supplied. The lack of government measures to encourage joint pain injections, however, limits the market's growth.

COVID-19 Impact:

The COVID-19 pandemic has turned out to be an unparalleled worldwide public health disaster that has impacted practically every business, and its repercussions are anticipated to have an impact on every industry's growth over the projection period. Globally, there have been several shifts in supply chain rerouting, purchasing patterns, customer demand and behavior, and major government efforts. The epidemic has altered people's lifestyles, drug usage patterns, and other health-related habits.

The hyaluronic acid injections segment is expected to be the largest during the forecast period

The hyaluronic acid injections segment is expected to be the largest during the forecast period. Patients who have already tried ineffective treatments like acetaminophen and other opioids are treated with hyaluronic acid injections for knee discomfort associated with osteoarthritis. Injections of hyaluronic acid have grown in favor as a non-surgical treatment option, especially considering that physicians are generally reluctant to administer intraarticular corticosteroid injections on a regular basis.

The hospital pharmacies segment is expected to have the highest CAGR during the forecast period

The hospital pharmacies segment is expected to have the highest CAGR during the forecast period. Hospital pharmacies frequently employ medical professionals with specific training in injectable administration in addition to competent pharmacists, assuring correct technique and lowering the chance of problems. Patients have access to a wider range of pain management options, including different types of injections or combination therapies tailored to their specific needs.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to the high prevalence of musculoskeletal disorders, growing geriatric population. This is ascribed to a number of factors, including the large concentration of market participants in the area, the robust presence of industry companies in the area, improved healthcare infrastructure, and public and industry stakeholder knowledge of available technology. The market in this area is expanding due in part to a high rate of adoption of cutting-edge technology.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. The rising incidence of osteoarthritis and the entry of viscosupplement products by regional competitors are propelling the growth of the respective markets in each country. Furthermore, ideal circumstances for the patient population's acceptance of these therapies are created by the growing knowledge of cutting-edge joint pain treatments in the area.

Key players in the market:

Some of the key players in Joint Pain Injections market include Anika Therapeutics, Inc., Sanofi aventis LLC, Ferring B.V., Zimmer Biomet, Bioventus LLC, Allergen Plc., Pfizer Inc., Chugai Pharmaceutical Co. Ltd, SEIKAGAKU Corporation, Ferring B.V., Pacira Biosciences, OrthogenRx, Pfizer, Lifecore Biomedical, Wright Medical Group, AbbVie and Stryker.

Key Developments:

In January 2023, AbbVie received the United States Food and Drug Administration (FDA) approval for SKYRIZI (risankizumab-rzaa) for the treatment of adults with active psoriatic arthritis (PsA), which can be administered with a single injection four times a year.

In March 2022, Sanofi collaborated with IGM Biosciences Inc. to develop, manufacture, and introduce potential therapeutics in the fields of immunology and inflammation.

Joint Types Covered:

Shoulder and Elbow
Facet Joints of the Spine
Knee and Ankle
Hip Joint
Other Joint Types

Injection Types Covered:

Interleukin Inhibitors
Hyaluronic Acid Injections
Steroid Joint Injections
Platelet-rich Plasma (PRP) Injections
Placental Tissue Matrix (PTM) Injections
Other Injection Types

Distribution Channels Covered:

Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

End Users Covered:

Hospitals
Clinics
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introducton
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Joint Pain Injections Market, By Joint Type

5.1 Introduction
5.2 Shoulder and Elbow
5.3 Facet Joints of the Spine
5.4 Knee and Ankle
5.5 Hip Joint
5.6 Other Joint Types

6 Global Joint Pain Injections Market, By Injection Type

6.1 Introduction
6.2 Interleukin Inhibitors
6.3 Hyaluronic Acid Injections
6.4 Steroid Joint Injections
6.5 Platelet-rich Plasma (PRP) Injections
6.6 Placental Tissue Matrix (PTM) Injections
6.7 Other Injection Types

7 Global Joint Pain Injections Market, By Distribution Channel

7.1 Introduction
7.2 Retail Pharmacies
7.3 Hospital Pharmacies
7.4 Online Pharmacies

8 Global Joint Pain Injections Market, By End User

8.1 Introduction
8.2 Hospitals
8.3 Clinics
8.4 Other End Users

9 Global Joint Pain Injections Market, By Geography

9.1 Introduction
9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa

10 Key Developments

10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling

11.1 Anika Therapeutics, Inc.
11.2 Sanofi aventis LLC
11.3 Ferring B.V.
11.4 Zimmer Biomet
11.5 Bioventus LLC
11.6 Allergen Plc.
11.7 Pfizer Inc.
11.8 Chugai Pharmaceutical Co. Ltd
11.9 SEIKAGAKU Corporation
11.10 Ferring B.V.
11.11 Pacira Biosciences
11.12 OrthogenRx
11.13 Pfizer
11.14 Lifecore Biomedical
11.15 Wright Medical Group
11.16 AbbVie
11.17 Stryker

関節痛注射の2030年までの市場予測：関節タイプ、注射タイプ、流通チャネル、エンドユーザー、地域別の世界分析

Joint Pain Injections Market Forecasts to 2030 - Global Analysis By Joint Type (Shoulder and Elbow, Facet Joints of the Spine, Knee and Ankle, Hip Joint and Other Joint Types), Injection Type, Distribution Channel, End User and By Geography

COVID-19の影響：

最大のシェアを占める地域

CAGRが最も高い地域：

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界の関節痛注射市場：関節タイプ別

第6章 世界の関節痛注射市場：注射タイプ別

第7章 世界の関節痛注射市場：流通チャネル別

第8章 世界の関節痛注射市場：エンドユーザー別

第9章 世界の関節痛注射市場：地域別

第10章 主な発展

第11章 企業プロファイル